GPX4 and cancer: Indeed, high levels of GSH are observed in the majority of tumors, contributing to cancer progression and treatment resistance in part by preventing glutathione peroxidase 4–dependent (GPX4-dependent) ferroptosis, an iron-dependent programmed cell death (5).